The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Maybe their thinking of delisting and going private then raising cash like LOOP have done recently, that's my worry when directors hold so many shares. I'm so underwater here it's laughable or cryable !!..my day's of investing in the junior market are well and truly over...been bitten way too many times..got more chance of been profitible at my local casino !
Possibly down to their last £1.5m, no doubt explains why the concert party was broken up to allow them to participate in any rounds of fundraising at a discount to what they have previous paid..in essence average down..which I'm personally sick of doing !
After many average downs since the IPO, I had my chance to exit with a small profit in June when the sp hit a heady 18.5p..gut feeling was to sell and finally be riddance...but I went with my heart..and here we are now..in the gutters again...don't expect anything of note tomorrow..so more pain on the way !!
Shame really, though we might begin the new year with more momentum. Don't expect any great announcements at the AGM possible trading update but there maybe a drag on sales due to the current economic environment
Shame really, though we might begin the new year with more momentum. Don't expect any great announcements at the AGM possible trading update but there maybe a drag on sales due to the current economic environment
Like many others I've been in this stock not long after listing and it's been one long painful ride which if I sold out now would cost me a shedload of wonga, but besides the turbulence, up's and downs, lawsuits and failed contracts.. I still believe deep in my heart they are in the right environment to be successful..ABDX were a trailblazer in a new market place which as expected has led to much speculation and volatility of which in most cases can destroy a less determined company...but these guys in charge have the perseverance, knowhow and balls to take on the challenges get through them and hopefully to produce the goods come tuesday..this really could just be the beginning for Abingdon ...fingers crossed
Thinking about it maybe fall might have something to do with Deepverge suspension and potential administration. ABDX signed a collaboration with DVRG early last year to develop and provide LFT's..take it that money invested is shot to the wall now..hope there is no outstanding debt owed.
This stock has been an easy play for MM's manipulation, hence the rise last week for no apparent reasoning and the subsequent fall today. Results this week should give us more clarity in the direction the company is facing.
At this price with money in the bank, in a lucrative marketplace and prospective pipeline of work surely predators must be eying up Abingdon as an established manufacturer. Venture capitalists MaSa partners look like an interesting fit co-founded by former director Max Duckworth who holds 12% of ABDX...others to keep an eye are Avacta, Arise Biotech, and possibly Deepverge. Reading between the lines the recent trading update pretty much put the for sale sign up and Chris Hand has sold his companies on before ie..cozart for £64m in 2007...just a thought !!!
Makes me laugh, Melanie Ross new CFO in April 2021 buys over 5k worth of shares at 93p, yet has felt no reason to buy anymore at this rock bottom price including at the placing price of 25p in December...shows how much faith she has with this company....and thats our CFO for christ sake !!!!
The reason the price is low, is the fact that ABDX have over promised and failed to deliver on numerous occasions, the recent trading update highlighted the incompetence of the current management team that have successfully eroded any real value in this company since the IPO late 2020. You could try and lay the blame at the door of the likes of GLP, DHSC, Avacta, mystery European partner or even Vatic but Hand and Yates between would have been at the forefront of these deals and its obvious to me their negotiation skills leave a lot to be desired. ABDX are in the sweet spot of cutting edge technology that could make them some serious ££ and that was my primary reason for investing in them in the 1st place but it's been an incredibly dissapointing ride so far and investor sentiment has been shot to pieces....hence why we sit at 7.75p ...9 mil market cap
I suspect we are awaiting the outcome of the case brought by GLP, before the government get involved with using Abingdon again..just need more patience..and I've had to have plenty of that since the IPO